West Pharmaceutical Services, Inc. (WST)
USD 325.32
(-2.67%)
USD 325.32
(-2.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.82 Billion USD | 5.88% |
| 2022 | 3.61 Billion USD | 9.14% |
| 2021 | 3.31 Billion USD | 18.61% |
| 2020 | 2.79 Billion USD | 19.32% |
| 2019 | 2.34 Billion USD | 47.04% |
| 2018 | 1.59 Billion USD | -14.52% |
| 2017 | 1.86 Billion USD | 8.51% |
| 2016 | 1.71 Billion USD | 1.27% |
| 2015 | 1.69 Billion USD | 1.45% |
| 2014 | 1.67 Billion USD | -0.04% |
| 2013 | 1.67 Billion USD | 6.88% |
| 2012 | 1.56 Billion USD | 11.79% |
| 2011 | 1.39 Billion USD | 8.1% |
| 2010 | 1.29 Billion USD | 1.83% |
| 2009 | 1.27 Billion USD | 8.75% |
| 2008 | 1.16 Billion USD | -1.43% |
| 2007 | 1.18 Billion USD | 29.12% |
| 2006 | 918.2 Million USD | 11.49% |
| 2005 | 823.6 Million USD | 25.03% |
| 2004 | 658.7 Million USD | 5.63% |
| 2003 | 623.6 Million USD | 16.17% |
| 2002 | 536.8 Million USD | 4.99% |
| 2001 | 511.3 Million USD | -8.27% |
| 2000 | 557.4 Million USD | 1.01% |
| 1999 | 551.8 Million USD | 9.14% |
| 1998 | 505.6 Million USD | 5.8% |
| 1997 | 477.9 Million USD | 0.1% |
| 1996 | 477.4 Million USD | -0.56% |
| 1995 | 480.1 Million USD | 20.81% |
| 1994 | 397.4 Million USD | 29.28% |
| 1993 | 307.4 Million USD | 0.99% |
| 1992 | 304.4 Million USD | -2.81% |
| 1991 | 313.2 Million USD | -8.82% |
| 1990 | 343.5 Million USD | 9.74% |
| 1989 | 313 Million USD | 4.72% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.67 Billion USD | 5.32% |
| 2024 Q1 | 3.6 Billion USD | -5.93% |
| 2024 Q2 | 3.48 Billion USD | -3.13% |
| 2023 Q2 | 3.66 Billion USD | -1.45% |
| 2023 FY | 3.82 Billion USD | 5.88% |
| 2023 Q1 | 3.72 Billion USD | 2.95% |
| 2023 Q3 | 3.75 Billion USD | 2.32% |
| 2023 Q4 | 3.82 Billion USD | 1.99% |
| 2022 Q1 | 3.29 Billion USD | -0.58% |
| 2022 FY | 3.61 Billion USD | 9.14% |
| 2022 Q4 | 3.61 Billion USD | 9.04% |
| 2022 Q3 | 3.31 Billion USD | -1.34% |
| 2022 Q2 | 3.36 Billion USD | 2.03% |
| 2021 FY | 3.31 Billion USD | 18.61% |
| 2021 Q4 | 3.31 Billion USD | 5.45% |
| 2021 Q3 | 3.14 Billion USD | 7.13% |
| 2021 Q2 | 2.93 Billion USD | 7.07% |
| 2021 Q1 | 2.73 Billion USD | -1.94% |
| 2020 Q4 | 2.79 Billion USD | 8.17% |
| 2020 Q1 | 2.24 Billion USD | -4.05% |
| 2020 Q3 | 2.58 Billion USD | 7.96% |
| 2020 Q2 | 2.39 Billion USD | 6.49% |
| 2020 FY | 2.79 Billion USD | 19.32% |
| 2019 Q4 | 2.34 Billion USD | 7.7% |
| 2019 FY | 2.34 Billion USD | 47.04% |
| 2019 Q1 | 2.03 Billion USD | 27.87% |
| 2019 Q2 | 2.12 Billion USD | 4.27% |
| 2019 Q3 | 2.17 Billion USD | 2.39% |
| 2018 Q4 | 1.59 Billion USD | -18.17% |
| 2018 Q2 | 1.87 Billion USD | 0.22% |
| 2018 Q3 | 1.94 Billion USD | 3.86% |
| 2018 Q1 | 1.86 Billion USD | 0.37% |
| 2018 FY | 1.59 Billion USD | -14.52% |
| 2017 Q2 | 1.84 Billion USD | 6.32% |
| 2017 FY | 1.86 Billion USD | 8.51% |
| 2017 Q4 | 1.86 Billion USD | -3.5% |
| 2017 Q3 | 1.93 Billion USD | 4.74% |
| 2017 Q1 | 1.73 Billion USD | 0.98% |
| 2016 Q2 | 1.7 Billion USD | 2.21% |
| 2016 FY | 1.71 Billion USD | 1.27% |
| 2016 Q4 | 1.71 Billion USD | -1.07% |
| 2016 Q3 | 1.73 Billion USD | 1.77% |
| 2016 Q1 | 1.66 Billion USD | -1.59% |
| 2015 FY | 1.69 Billion USD | 1.45% |
| 2015 Q2 | 1.66 Billion USD | 4.24% |
| 2015 Q1 | 1.59 Billion USD | -4.48% |
| 2015 Q4 | 1.69 Billion USD | 1.72% |
| 2015 Q3 | 1.66 Billion USD | 0.17% |
| 2014 Q2 | 1.7 Billion USD | -0.2% |
| 2014 FY | 1.67 Billion USD | -0.04% |
| 2014 Q4 | 1.67 Billion USD | -0.14% |
| 2014 Q1 | 1.7 Billion USD | 2.19% |
| 2014 Q3 | 1.67 Billion USD | -1.84% |
| 2013 FY | 1.67 Billion USD | 6.88% |
| 2013 Q3 | 1.66 Billion USD | 3.21% |
| 2013 Q2 | 1.61 Billion USD | 2.26% |
| 2013 Q1 | 1.57 Billion USD | 0.84% |
| 2013 Q4 | 1.67 Billion USD | 0.43% |
| 2012 FY | 1.56 Billion USD | 11.79% |
| 2012 Q4 | 1.56 Billion USD | 2.4% |
| 2012 Q3 | 1.52 Billion USD | 4.42% |
| 2012 Q2 | 1.46 Billion USD | 0.38% |
| 2012 Q1 | 1.45 Billion USD | 4.16% |
| 2011 Q3 | 1.39 Billion USD | -1.2% |
| 2011 Q1 | 1.36 Billion USD | 5.55% |
| 2011 Q4 | 1.39 Billion USD | 0.06% |
| 2011 FY | 1.39 Billion USD | 8.1% |
| 2011 Q2 | 1.41 Billion USD | 3.6% |
| 2010 FY | 1.29 Billion USD | 1.83% |
| 2010 Q1 | 1.25 Billion USD | -1.37% |
| 2010 Q2 | 1.22 Billion USD | -2.51% |
| 2010 Q3 | 1.29 Billion USD | 6.34% |
| 2010 Q4 | 1.29 Billion USD | -0.41% |
| 2009 Q2 | 1.21 Billion USD | 6.66% |
| 2009 Q3 | 1.26 Billion USD | 3.81% |
| 2009 Q4 | 1.27 Billion USD | 0.56% |
| 2009 Q1 | 1.14 Billion USD | -2.33% |
| 2009 FY | 1.27 Billion USD | 8.75% |
| 2008 FY | 1.16 Billion USD | -1.43% |
| 2008 Q1 | 1.21 Billion USD | 2.13% |
| 2008 Q3 | 1.21 Billion USD | -3.46% |
| 2008 Q4 | 1.16 Billion USD | -3.41% |
| 2008 Q2 | 1.25 Billion USD | 3.52% |
| 2007 Q3 | 1.15 Billion USD | 1.1% |
| 2007 Q4 | 1.18 Billion USD | 2.62% |
| 2007 Q2 | 1.14 Billion USD | 3.3% |
| 2007 Q1 | 1.1 Billion USD | 20.47% |
| 2007 FY | 1.18 Billion USD | 29.12% |
| 2006 Q1 | 851.5 Million USD | 3.39% |
| 2006 Q3 | 895 Million USD | 1.29% |
| 2006 Q4 | 918.2 Million USD | 2.59% |
| 2006 FY | 918.2 Million USD | 11.49% |
| 2006 Q2 | 883.6 Million USD | 3.77% |
| 2005 Q1 | 650 Million USD | -1.32% |
| 2005 FY | 823.6 Million USD | 25.03% |
| 2005 Q2 | 797.8 Million USD | 22.74% |
| 2005 Q3 | 799.5 Million USD | 0.21% |
| 2005 Q4 | 823.6 Million USD | 3.01% |
| 2004 Q3 | 636.2 Million USD | 2.9% |
| 2004 FY | 658.7 Million USD | 5.63% |
| 2004 Q1 | 604.8 Million USD | -3.01% |
| 2004 Q2 | 618.3 Million USD | 2.23% |
| 2004 Q4 | 658.7 Million USD | 3.54% |
| 2003 Q4 | 623.6 Million USD | 8.34% |
| 2003 Q2 | 567.4 Million USD | 4.71% |
| 2003 Q3 | 575.6 Million USD | 1.45% |
| 2003 Q1 | 541.9 Million USD | 0.95% |
| 2003 FY | 623.6 Million USD | 16.17% |
| 2002 Q3 | 516.4 Million USD | -1.66% |
| 2002 Q2 | 525.1 Million USD | 3.63% |
| 2002 FY | 536.8 Million USD | 4.99% |
| 2002 Q4 | 536.8 Million USD | 3.95% |
| 2002 Q1 | 506.7 Million USD | -0.9% |
| 2001 Q1 | 556.3 Million USD | -0.2% |
| 2001 Q4 | 511.3 Million USD | -11.31% |
| 2001 FY | 511.3 Million USD | -8.27% |
| 2001 Q3 | 576.5 Million USD | 3.76% |
| 2001 Q2 | 555.6 Million USD | -0.13% |
| 2000 FY | 557.4 Million USD | 1.01% |
| 2000 Q4 | 557.4 Million USD | -0.82% |
| 2000 Q3 | 562 Million USD | 1.12% |
| 2000 Q1 | 562.8 Million USD | 1.99% |
| 2000 Q2 | 555.8 Million USD | -1.24% |
| 1999 FY | 551.8 Million USD | 9.14% |
| 1999 Q3 | 540.9 Million USD | 2.06% |
| 1999 Q4 | 551.8 Million USD | 2.02% |
| 1999 Q2 | 530 Million USD | 5.94% |
| 1999 Q1 | 500.3 Million USD | -1.05% |
| 1998 Q1 | 508.4 Million USD | 6.38% |
| 1998 Q2 | 496.5 Million USD | -2.34% |
| 1998 Q3 | 521.7 Million USD | 5.08% |
| 1998 Q4 | 505.6 Million USD | -3.09% |
| 1998 FY | 505.6 Million USD | 5.8% |
| 1997 Q3 | 485.8 Million USD | 2.14% |
| 1997 Q1 | 476.5 Million USD | -0.19% |
| 1997 Q2 | 475.6 Million USD | -0.19% |
| 1997 Q4 | 477.9 Million USD | -1.63% |
| 1997 FY | 477.9 Million USD | 0.1% |
| 1996 FY | 477.4 Million USD | -0.56% |
| 1996 Q4 | 477.4 Million USD | 2.01% |
| 1996 Q1 | 469.7 Million USD | -2.17% |
| 1996 Q3 | 468 Million USD | 0.13% |
| 1996 Q2 | 467.4 Million USD | -0.49% |
| 1995 Q2 | 485.1 Million USD | 15.06% |
| 1995 Q1 | 421.6 Million USD | 6.09% |
| 1995 Q4 | 480.1 Million USD | 0.5% |
| 1995 FY | 480.1 Million USD | 20.81% |
| 1995 Q3 | 477.7 Million USD | -1.53% |
| 1994 Q2 | 351.7 Million USD | 7.75% |
| 1994 Q3 | 363.7 Million USD | 3.41% |
| 1994 Q4 | 397.4 Million USD | 9.27% |
| 1994 FY | 397.4 Million USD | 29.28% |
| 1994 Q1 | 326.4 Million USD | 6.18% |
| 1993 Q2 | 318.5 Million USD | 3.81% |
| 1993 FY | 307.4 Million USD | 0.99% |
| 1993 Q4 | 307.4 Million USD | -1.66% |
| 1993 Q3 | 312.6 Million USD | -1.85% |
| 1993 Q1 | 306.8 Million USD | 0.79% |
| 1992 Q2 | 312.2 Million USD | -0.57% |
| 1992 Q4 | 304.4 Million USD | -7.28% |
| 1992 FY | 304.4 Million USD | -2.81% |
| 1992 Q3 | 328.3 Million USD | 5.16% |
| 1992 Q1 | 314 Million USD | 0.26% |
| 1991 Q3 | 320.4 Million USD | -1.6% |
| 1991 Q4 | 313.2 Million USD | -2.25% |
| 1991 Q1 | 346.2 Million USD | 0.79% |
| 1991 FY | 313.2 Million USD | -8.82% |
| 1991 Q2 | 325.6 Million USD | -5.95% |
| 1990 Q1 | 326.5 Million USD | 4.31% |
| 1990 Q2 | 334.4 Million USD | 2.42% |
| 1990 Q4 | 343.5 Million USD | 1.45% |
| 1990 Q3 | 338.6 Million USD | 1.26% |
| 1990 FY | 343.5 Million USD | 9.74% |
| 1989 FY | 313 Million USD | 4.72% |
| 1989 Q4 | 313 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alcon Inc. | 29.6 Billion USD | 87.064% |
| AptarGroup, Inc. | 4.45 Billion USD | 13.98% |
| Baxter International Inc. | 28.27 Billion USD | 86.457% |
| Becton, Dickinson and Company | 52.78 Billion USD | 92.744% |
| Bausch + Lomb Corporation | 13.44 Billion USD | 71.511% |
| Haemonetics Corporation | 2.19 Billion USD | -74.418% |
| Envista Holdings Corp | 6.6 Billion USD | 42.022% |
| ResMed Inc. | 6.87 Billion USD | 44.277% |
| Teleflex Incorporated | 7.53 Billion USD | 49.161% |
| Warby Parker Inc. | 580.31 Million USD | -559.904% |